- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (236)
- Breast Cancer (714)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (166)
- Colorectal Cancer (108)
- Endocrine Tumor (4)
- Esophageal Cancer (40)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (2)
- Kidney Cancer (124)
- Leukemia (352)
- Liver Cancer (50)
- Lung Cancer (290)
- Lymphoma (286)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (102)
- Myelodysplastic Syndrome (64)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (102)
- Ovarian Cancer (176)
- Pancreatic Cancer (172)
- Parathyroid Disease (2)
- Penile Cancer (16)
- Pituitary Tumor (6)
- Prostate Cancer (148)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (296)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (58)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (32)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (8)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (624)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (222)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (874)
- Research (402)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (600)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (324)
- Symptoms (180)
- Treatment (1762)
New Screening Tool for Lung Cancer Brings Hope
2 minute read | Published June 29, 2011
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on June 29, 2011
Lung cancer is the leading cause of death for men and women in the United States, with more than 157,000 deaths reported last year, according to the National Cancer Institute. Most lung cancers are caused by tobacco smoke. The longer a person is exposed to the smoke the greater the risk for developing the disease.
"On average, lung cancer is typically diagnosed in the later stages of the disease when it is extremely difficult to treat," says Reginald Munden, M.D., a professor in the Department of Diagnostic Radiology and MD Anderson's principal investigator on the clinical trial. In the NLST, the low-dose spiral CT scan identified more tumors at early stages, when they are more easily treated.
Study results translate into action
In response, MD Anderson has launched a lung cancer screening program for current and former smokers age 50 years or older who have smoked a pack of cigarettes a day for at least 20 years.
The comprehensive program was developed to help prevent lung cancer deaths by using tools designed to detect lung cancer in its earliest stages, while offering a multidisciplinary team of experts to analyze results. In addition, MD Anderson provides smoking-cessation programs and risk assessments geared at challenging smokers to make appropriate lifestyle changes to increase their chances for survival.
Therese Bevers, M.D., medical director of the Cancer Prevention Center at MD Anderson, adds recommended screenings to the top of that list.
"Some cancers are preventable and treatable if detected early," says Bevers, M.D., who also is MD Anderson's co-investigator on the national trial. "Because the standard chest X-ray is unable to detect lung cancer when it is small, we recommend CT scanning as the screening tool for lung cancer."
Munden understands that screening offers more than just hope to former and current smokers who are at risk for developing cancer, it also provides an opportunity to make the individual healthy overall. "During the trial, we discovered some participants at increased risk for other health risks and potential diseases," he says.
Listen to Munden and Bevers talk in depth about the study results and the screening (audio)
Because the standard chest X-ray is unable to detect lung cancer when it is small, we recommend CT scanning as the screening tool for lung cancer.
Therese Beavers, M.D.
Physician